Skip to main content

Table 6 Bacterial culture results, complications, and treatment of 83 deaths with COVID-19 pneumonia after admission

From: Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series

 

Patients, n(%)

Bacterial culture results

36(43.4%)

 Sputum bacteria culture positive

22(26.5%)

 Blood bacteria culture positive

9(10.8%)

 Urine bacteria culture positive

5(6.2%)

 Fecal bacteria culture positive

0

Complications

 Acute respiratory failure

71(85.5%)

 Acute myocardial infarction

6(7.2%)

 Heart failure

37(44.6%)

 Acute liver injury

9(10.8%)

 Acute kidney injury

22(26.5%)

 Gastrointestinal bleeding

16(19.2%)

 Sepsis

69(83.1%)

 Shock

33(39.8%)

Treatments

 Antiviral therapy

83(100%)

  Monotherapy

   Abidole

6(7.2%)

  Combination therapyAbidole

   Abidole/ Oseltamivir

57(68.7%)

   Abidole/ Ribavirin

16(19.3%)

   Abidole/ Lopinavir and Ritonavir

3(3.6%)

   Abidole/ Oseltamivir/ Lopinavir and Ritonavir

1(1.2%%)

 Antifungal therapy

2(2.4%%)

 Antibiotic therapy

81(97.6%)

  Penicillins

24(28.9%)

  Cephalosporins

52(62.7%)

  Quinolone

35(42.2%)

  Vancomycin

11(13.3%)

 Glucocorticoid therapy

54(65.1%)

 Intravenous immunoglobulin therapy

39(47.0%)

 CRRT

6(7.3%)

 Invasive mechanical ventilation

20(24.1%)

 Non-invasive mechanical ventilation

51(61.4%)

 High flow nasal cannula

12(14.5%)

 ECMO

1(1.2%)

  1. CRRT continuous renal replacement therapy, ECMO extracorporeal membrane oxygenation